Biotech CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596 December 29, 2025
Biotech Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy December 28, 2025
Biotech ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly December 27, 2025
Biotech From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream December 27, 2025
Biotech Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 V617F, into First-in-Human Clinical Development December 18, 2025
Biotech Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout December 15, 2025
Biotech BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair December 10, 2025